Hollsteen
← NXP

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 2018: $433M · 10-Q 0001413447-19-000035 filed Oct 29, 2019Research and development · Q4 2018: $403M · derived · 10-K 0001413447-20-000009 filed Feb 27, 2020Research and development · Q1 2019: $415M · 10-Q 0001413447-20-000026 filed Apr 28, 2020Research and development · Q2 2019: $408M · 10-Q 0001413447-20-000056 filed Jul 28, 2020Research and development · Q3 2019: $396M · 10-Q 0001413447-19-000035 filed Oct 29, 2019Research and development · Q4 2019: $424M · derived · 10-K 0001413447-21-000011 filed Feb 25, 2021Research and development · Q1 2020: $425M · 10-Q 0001413447-20-000026 filed Apr 28, 2020Research and development · Q2 2020: $402M · 10-Q 0001413447-20-000056 filed Jul 28, 2020Research and development · Q3 2020: $438M · 10-Q 0001413447-20-000084 filed Oct 27, 2020Research and development · Q4 2020: $460M · derived · 10-K 0001413447-22-000008 filed Feb 24, 2022Research and development · Q1 2021: $461M · 10-Q 0001413447-21-000032 filed Apr 27, 2021Research and development · Q2 2021: $476M · 10-Q 0001413447-21-000062 filed Aug 3, 2021Research and development · Q3 2021: $492M · 10-Q 0001413447-21-000094 filed Nov 2, 2021Research and development · Q4 2021: $507M · derived · 10-K 0001413447-23-000006 filed Mar 1, 2023Research and development · Q1 2022: $518M · 10-Q 0001413447-22-000014 filed May 3, 2022Research and development · Q2 2022: $542M · 10-Q 0001413447-22-000049 filed Jul 26, 2022Research and development · Q3 2022: $548M · 10-Q 0001413447-22-000067 filed Nov 1, 2022Research and development · Q4 2022: $540M · derived · 10-K 0001413447-24-000013 filed Feb 22, 2024Research and development · Q1 2023: $577M · 10-Q 0001413447-23-000020 filed May 2, 2023Research and development · Q2 2023: $589M · 10-Q 0001413447-23-000059 filed Jul 25, 2023Research and development · Q3 2023: $601M · 10-Q 0001413447-23-000107 filed Nov 7, 2023Research and development · Q4 2023: $651M · derived · 10-K 0001413447-25-000019 filed Feb 20, 2025Research and development · Q1 2024: $564M · 10-Q 0001413447-24-000038 filed Apr 30, 2024Research and development · Q2 2024: $594M · 10-Q 0001413447-24-000072 filed Jul 23, 2024Research and development · Q3 2024: $577M · 10-Q 0001413447-24-000089 filed Nov 5, 2024Research and development · Q4 2024: $612M · derived · 10-K 0001413447-26-000008 filed Feb 19, 2026Research and development · Q1 2025: $547M · 10-Q 0001413447-25-000031 filed Apr 29, 2025Research and development · Q2 2025: $573M · 10-Q 0001413447-25-000106 filed Jul 24, 2025Research and development · Q3 2025: $575M · 10-Q 0001413447-25-000120 filed Oct 28, 2025Research and development · Q4 2025: $665M · derived · 10-K 0001413447-26-000008 filed Feb 19, 2026Research and development · Q1 2026: $588M · 10-Q 0001413447-26-000034 filed Apr 28, 2026missing594588433665aQ1 2016Q1 2026Q2 2024
$MResearch and development · Q2 2024: $594M · 10-Q 0001413447-24-000072 filed Jul 23, 2024Research and development · Q3 2024: $577M · 10-Q 0001413447-24-000089 filed Nov 5, 2024Research and development · Q4 2024: $612M · derived · 10-K 0001413447-26-000008 filed Feb 19, 2026Research and development · Q1 2025: $547M · 10-Q 0001413447-25-000031 filed Apr 29, 2025Research and development · Q2 2025: $573M · 10-Q 0001413447-25-000106 filed Jul 24, 2025Research and development · Q3 2025: $575M · 10-Q 0001413447-25-000120 filed Oct 28, 2025Research and development · Q4 2025: $665M · derived · 10-K 0001413447-26-000008 filed Feb 19, 2026Research and development · Q1 2026: $588M · 10-Q 0001413447-26-000034 filed Apr 28, 2026594588665aQ2 2024Q1 2026Q2 2025
Q2 2024
594$M
All values (31)
PeriodValue ($M)Status
Q1 2026588reported
Q4 2025665derived
Q3 2025575reported
Q2 2025573reported
Q1 2025547reported
Q4 2024612derived
Q3 2024577reported
Q2 2024594reported
Q1 2024564reported
Q4 2023651derived
Q3 2023601reported
Q2 2023589reported
Q1 2023577reported
Q4 2022540derived
Q3 2022548reported
Q2 2022542reported
Q1 2022518reported
Q4 2021507derived
Q3 2021492reported
Q2 2021476reported
Q1 2021461reported
Q4 2020460derived
Q3 2020438reported
Q2 2020402reported
Q1 2020425reported
Q4 2019424derived
Q3 2019396reported
Q2 2019408reported
Q1 2019415reported
Q4 2018403derived
Q3 2018433reported

10 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: rnd

More metrics for NXP

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$594M
Period
Q2 2024, ended Jun 30, 2024 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Jul 23, 2024 · 0001413447-24-000072
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$594MJul 23, 202410-Q 0001413447-24-000072reported · confidence 1. · current